ESC Premium Access

Impact of atrial fibrillation on biomarkers predicting severity of coronary artery disease in patients with suspected coronary heart disease: baseline data from the ANOX study

Congress Session

About the speaker

Doctor Hiromichi Wada

Kyoto Medical Centre, Kyoto (Japan)
0 follower

7 more presentations in this session

Plasma trimethylamine-N-oxide is associated with atrial fibrillation

Speaker: Doctor G. Svingen (Bergen, NO)


Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation : an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients.

Speaker: Doctor Y. Purmah (Birmingham, GB)


NT-proBNP is a more sensitive and specific biomarker for the prediction of future atrial fibrillation than for forthcoming onset of heart failure: results from the observational DIAST-CHF study

Speaker: Miss S. Werhahn (Göttingen, DE)


Circulating lipopolysaccharides and risk of major adverse cardiovascular events in atrial fibrillation: association with mediterranean diet adherence

Speaker: Associate Professor D. Pastori (Rome, IT)


Effect of rivaroxaban on coagulation and inflammation biomarkers: results from an X-VeRT substudy

Speaker: Doctor Y. Purmah (Birmingham, GB)


Access the full session

Poster session 3 - Biomarkers - Heart Failure

Speakers: Doctor H. Wada, Doctor G. Svingen, Doctor Y. Purmah, Miss S. Werhahn, Associate Professor D. Pastori...

About the event



26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk